|
|
|
Gabapentin Hydrochloride |
Enrofloxacin Hydrochloride |
Ciprofloxacin Hydrochloride |
Pioglitazone Hydrochloride |
Terbinafine Hydrochloride |
Fluoxetine Hydrochloride |
Fluoxetine hydrochloride intermediate |
Clopidogrel |
Imatinib Intermediate |
Telmisartan Intermediate |
Gefitinib Intermediate |
Acyclovir intermediate |
Erlotinib Intermediate |
Lapatinib Intermediate |
Atazanavir Intermediate |
Sitagliptin intermediate |
|
|
|
|
Products |
|
Chiral Spiro Ligands for Asymmetric Catalyst>> |
Chiral Spiro Ligands for Asymmetric Catalyst |
JiuZhou No. |
Chemical Name |
Structure Formula |
[α]D20 |
CAS Reg.No |
Acronym |
M.P. ℃ |
Abs. Config. |
MF, MW |
Purity
HPLC |
JZ-S001-1 |
N-Dimethyl-[(R)-1,1'-spirobiindane-7,7'diyl]phosphoramidite |
|
+505
(c 0.5,
CH2Cl2) |
[443965-14-8] |
(R)-SIPHOS |
95-96 |
( R ) |
C19H20NO2P
FW: 325.34 |
≥98% |
JZ-S001-2 |
N-Dimethyl-[(S)-1,1'-spirobiindane-7,7'-diyl]phosphoramidite |
|
-502
(c 0.5,
CH2Cl2) |
[443965-10-4] |
(S)-SIPHOS |
95-96 |
( S ) |
C19H20NO2P
FW: 325.34 |
≥98% |
JZ-S002-1 |
Phenyl-[(R)-1,1'-spirobiindane-7,7'-diyl]-phosphite |
|
+216
(c 0.5,
CH2Cl2) |
[656233-53-3] |
(R)-ShiP |
104-105 |
( R ) |
C23H19O3P
FW: 374.37 |
≥98% |
JZ-S002-2 |
Phenyl-[(S)-1,1'-spirobiindane-7,7'-diyl]-phosphite |
|
-215
(c 0.51,
CH2Cl2) |
[885701-71-3] |
(S)-ShiP |
104-105 |
( S ) |
C23H19O3P
FW: 374.37 |
≥98% |
JZ-S003-1 |
N-Di[(R)-1-phenylethyl]-[(R)-1,1'-spirobiindane-7,7'-diyl]-phosphoramidite |
|
+300
(c 1.0,
CH2Cl2) |
[500997-69-3] |
(Ra,R,R)-SIPHOS-PE |
98-100 |
( Ra,R,R ) |
C33H32NO2P
FW: 505.59 |
≥98% |
JZ-S003-2 |
N-Di[(R)-1-phenylethyl]-[(S)-1,1'-spirobiindane-7,7'-diyl]-phosphoramidite |
|
-63.5
(c 1.0,
CH2Cl2) |
[500997-70-6] |
(Sa,R,R)-SIPHOS-PE |
99-101 |
( Sa,R,R ) |
C33H32NO2P
FW: 505.59 |
≥98% |
JZ-S004-1 |
(R)–7,7'-bis(diphenylphosphino)-1,1'-spirobiindane |
|
+207
(c 0.5,
CH2Cl2) |
[917377-74-3 ] |
(R)-SDP |
200-202 |
( R ) |
C41H34P2
FW: 588.66 |
≥97% |
JZ-S004-2 |
(S)–7,7'-bis(diphenylphosphino)-1,1'-spirobiindane |
|
-203
(c 0.5,
CH2Cl2) |
[528521-86-0 ] |
(S)-SDP |
206-208 |
( S ) |
C41H34P2
FW: 588.66 |
≥97% |
JZ-S005-1 |
(R)–7,7'-Bis[di(p-methylphenyl)phosphino]-1,1'-spirobiindane |
|
+212
(c 0.53,
CH2Cl2) |
[528521-87-1 ] |
(R)-Tol-SDP |
150-152 |
( R ) |
C45H42P2
FW: 644.76 |
≥97% |
JZ-S005-2 |
(S)–7,7'-Bis[di(p-methylphenyl)phosphino]-1,1'-spirobiindane |
|
-221
(c 0.54,
CH2Cl2) |
[817176-80-0 ] |
(S)-Tol-SDP |
150-152 |
( S ) |
C45H42P2
FW: 644.76 |
≥97% |
JZ-S006-1 |
(R)–7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-1,1'-spirobiindane |
|
+87.5
(c 0.53,
CH2Cl2) |
[917377-75-4 ] |
(R)-Xyl-SDP |
Oil |
( R ) |
C49H50P2
FW: 700.87 |
≥97% |
JZ-S006-2 |
(S)–7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-1,1'-spirobiindane |
|
-83
(c 0.53,
CH2Cl2) |
[528521-89-3 ] |
(S)-Xyl-SDP |
Oil |
( S ) |
C49H50P2
FW: 700.87 |
≥97% |
JZ-S007-1 |
(R)-O,O'-[7,7'-(1,1'-spirobiindan)]-tert-butylphosphonite |
|
+456
(c 1.2,
CH2Cl2) |
|
(R)-FuP-tBu |
|
( R ) |
C21H23O2P
FW: 338.38 |
≥97%
≥99%EE |
JZ-S007-2 |
(S)-O,O'-[7,7'-(1,1'-spirobiindan)]-tert-butylphosphonite |
|
-456
(c 1.2,
CH2Cl2) |
[912457-08-0] |
(S)-FuP-tBu |
|
( S ) |
C21H23O2P
FW: 338.38 |
≥97%
≥99%EE |
JZ-S008-1 |
(R)-dimethylene-[7,7'-(1,1'-spiroindan)]-phenylphospholane |
|
[α]D21:+6
(c 0.5,
CH2Cl2) |
[856407-37-9] |
(R)-SITCP |
148-149 |
( R ) |
C25H23P
FW: 354.42 |
≥97%
≥99%EE |
JZ-S008-2 |
(S)-dimethylene-[7,7'-(1,1'-spiroindan)]-phenylphospholane |
|
[α]D21:-6
(c 0.5,
CH2Cl2) |
[885701-78-0] |
(S)-SITCP |
148-149 |
( S ) |
C25H23P
FW: 354.42 |
≥97%
≥99%EE |
JZ-S009-1 |
(Ra,S)-7-[4-(Benzyl)oxazol-2-yl]-7'-diphenylphosphinyl-1,1'-spirobiinane |
|
|
|
(R,S)-Ph-Bn-SIPHOX |
98-100 |
( Ra,S ) |
C39H34NOP
FW: 563.67 |
≥97%
≥99%EE |
JZ-S009-2 |
(Sa,S)-7-[4-(Benzyl)oxazol-2-yl]-7'-diphenylphosphinyl-1,1'-spirobiinane |
|
-227.0
(c 0.5,
CH2Cl2) |
[913829-88-6] |
(Sa,S)-Ph-Bn-SIPHOX |
164-166 |
( Sa,S ) |
C39H34NOP
FW: 563.67 |
≥97%
≥99%EE |
JZ-S010-1 |
(S,S)-7-[4-(Benzyl)oxazol-2-yl]-7'-di(3,5-ditertbutylphenyl)phosphinyl-1,1'- spirobiindane |
|
[α]D25:
-185.6
(c 0.5,
CH2Cl2) |
[1040274-10-9] |
(S,S)-DTB-Bn-SIPHOX |
159-161 |
(S,S) |
C55H66NOP
FW: 788.09 |
≥97%
≥99%EE |
JZ-S011-1 |
(S)-7-(4,5-Dihydrooxazol-2-yl)-7'-di(3,5-ditertbutylphenyl)phosphino-1,1'- spirobiinane |
|
[α]D25:
-184.4
(c 0.5,
CH2Cl2) |
[1040274-18-7] |
(S)-DTB-SIPHOX |
229-231 |
( S ) |
C48H60NOP
FW: 697.97 |
≥97%
≥99%EE |
JZ-S012-1 |
(Sa,S)-7-[4-(Benzyl)oxazol-2-yl]-7-di(3,5-dimethylphenyl)phosphinyl-1,1- spirobiinane |
|
[α]D24:
-196.8
(c 0.51,
CH2Cl2) |
[913829-90-0] |
(Sa,S)-Xyl-Bn-SIPHOX |
Oil |
( Sa,S ) |
C43H42NOP
FW: 619.77 |
≥97%
≥99%EE |
JZ-S013-1 |
(Sa,S,S)-7,7'-bis(4'-phenyloxazol-2-yl)-1,1'-spirobiindane |
|
-322
(c 0.5,
CH2Cl2) |
[940880-69-3] |
(Sa,S,S)-SpiroBOX |
167-169 |
(Sa,S,S) |
C35H30N2O2
FW: 510.62 |
≥97% |
JZ-S013-2 |
(Ra,S,S)-7,7'-bis(4'-phenyloxazol-2-yl)-1,1'-spirobiindane |
|
+93
(c 0.5,
CH2Cl2) |
[890090-21-8] |
(Ra,S,S)-SpiroBOX |
130-132 |
(Ra,S,S) |
C35H30N2O2
FW: 510.62 |
≥97% |
|
|
|
|
|
|